Page 9 - NIPERs
P. 9

Promoting Excellence in Pharmaceutical Education and Research













               NIPER - Hyderabad                                  NIPER - Guwahati



               •  Integrated Drug Discovery and                   •  Development      of    drug    delivery
                 Product Development Programmes                      systems against Cancer.
                 in Cancer, Diabetes, other metabolic             •  Screening of NCE’s and North-East
                 disorders and Neurodegeneration.                    plant  products against  Parkinson’s
               •  Development of novel Process for                   Disease and Depression.
                 NCEs, Bulk Drugs and Intermediates.              •  Screening Indian biodiversity and
               •  Development of Analytical Methods,                 Indian Systems of Medicine for lead
                 Impurity Profiling and Stability                    molecules in inflammation, arthritis,
                 studies.                                            diabetes, and cancer.

               •  Solid state characterization.                   •  Study of drug utilization pattern for
               •  Targeted drug delivery systems.                    antiepileptic and antipsychotic drugs.
               •  Peptidomimetics as therapeutic                  •  Pharmaceutical 3D and 4D Printing
                                                                     Technology.
                 agents and Drug Delivery Systems.                •  Pharmacoengineered             delivery

               •  Bioavailability improvement using                  devices to fight against neglected
                 nanotechnology,           lipid-based               diseases.
                 systems and crystal engineering                  •  Bioavailability, IVIVC and IVIVE analysis.
                 techniques.
                                                                  •  Pharmacokinetic,         Toxicokinetic,
                                                                     Metabolic and Impurity profiling.





























                                                              9
   4   5   6   7   8   9   10   11   12   13   14